In over 60 patients with severe uncontrolled asthma who received anti-IL5/5R therapy, the baseline histopathologic score was a better predictor of response than T2 markers, indicating the potential benefits of tissue sampling to help guide therapy for patients with severe uncontrolled asthma [142]. Here, IL5 is linked to asthma.